Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Controlled Investigation on Action of Acarbose on the Sub-Clinical Inflammation and Immune Response in Early Type 2 Diabetes and Atherosclerosis Risk

NCT00558883 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT00558883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00558883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Controlled Investigation on Action of Acarbose on the Sub-Clinical Inflammation and Immune Response in Early Type 2 Diabetes and Atherosclerosis Risk
Lead sponsor
GWT-TUD GmbH
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2007
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subclinical inflammation, type 2 diabetes mellitus